galantamine and soman

galantamine has been researched along with soman in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (45.45)29.6817
2010's6 (54.55)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agnusdei, M; Belinskaya, T; Borriello, M; Brindisi, M; Butini, S; Campiani, G; Catalanotti, B; Fattorusso, C; Fiorini, I; Gemma, S; Nacci, V; Novellino, E; Panico, A; Persico, M; Ros, S; Saxena, A1
Adler, M; Albuquerque, EX; Aracava, Y; Fawcett, WP; Hamilton, TA; Kan, RK; Oliveira, M; Pereira, EF; Randall, WR; Romano, JA1
Kellar, KJ1
Albuquerque, EX; Alkondon, M; Aracava, Y; Pereira, EF1
Akkerman, M; Albuquerque, EX; Alkondon, M; Aracava, Y; Merchenthaler, I; Pereira, EF1
Adler, M; Akkerman, M; Albuquerque, EX; Aracava, Y; Pereira, EF1
Albuquerque, EX; Aracava, Y; Gullapalli, RP; Helal Neto, E; Makris, G; Merchenthaler, I; Pereira, EF; Wang, J; Zhuo, J1
Albuquerque, EX; Alexandrova, EA; Aracava, Y; Pereira, EF1
Albuquerque, EX; Kulkarni, GS; Mamczarz, J; Pereira, EF1
Albuquerque, EX; Alexandrova, EA; Alkondon, M; Aracava, Y; Pereira, EF1
Acharya, J; Dubey, DK; Golime, R; Palit, M1

Other Studies

11 other study(ies) available for galantamine and soman

ArticleYear
Exploiting protein fluctuations at the active-site gorge of human cholinesterases: further optimization of the design strategy to develop extremely potent inhibitors.
    Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11

    Topics: Acetylcholinesterase; Binding Sites; Butyrylcholinesterase; Cholinesterase Inhibitors; Computational Biology; Crystallography, X-Ray; Drug Design; Humans; Models, Molecular; Protein Conformation; Structure-Activity Relationship; Tacrine

2008
Effective countermeasure against poisoning by organophosphorus insecticides and nerve agents.
    Proceedings of the National Academy of Sciences of the United States of America, 2006, Aug-29, Volume: 103, Issue:35

    Topics: Acetylcholinesterase; Alkaloids; Animals; Atropine; Behavior, Animal; Brain; Chemical Warfare Agents; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Therapy, Combination; Galantamine; Guinea Pigs; Insecticides; Lethal Dose 50; Neurons; Organophosphate Poisoning; Organophosphorus Compounds; Paraoxon; Poisoning; Pyridostigmine Bromide; Sarin; Sesquiterpenes; Soman; Time Factors

2006
Overcoming inhibitions.
    Proceedings of the National Academy of Sciences of the United States of America, 2006, Sep-05, Volume: 103, Issue:36

    Topics: Acetylcholine; Acetylcholinesterase; Animals; Atropine; Benzodiazepines; Blood-Brain Barrier; Brain; Chemical Warfare Agents; Cholinesterase Inhibitors; Drug Therapy, Combination; Galantamine; Guinea Pigs; Insecticides; Neurons; Neurotransmitter Agents; Organophosphate Poisoning; Organophosphates; Organophosphorus Compounds; Paraoxon; Pralidoxime Compounds; Pyridostigmine Bromide; Receptors, Cholinergic; Receptors, Muscarinic; Sarin; Seizures; Soman; Time Factors

2006
A single in vivo application of cholinesterase inhibitors has neuron type-specific effects on nicotinic receptor activity in guinea pig hippocampus.
    The Journal of pharmacology and experimental therapeutics, 2009, Volume: 328, Issue:1

    Topics: Animals; Cholinesterase Inhibitors; Galantamine; Guinea Pigs; Hippocampus; In Vitro Techniques; Interneurons; Male; Neurons; Patch-Clamp Techniques; Pyramidal Cells; Receptors, Nicotinic; Soman; Survival Analysis

2009
Molecular and cellular actions of galantamine: clinical implications for treatment of organophosphorus poisoning.
    Journal of molecular neuroscience : MN, 2010, Volume: 40, Issue:1-2

    Topics: Acetylcholinesterase; Animals; Atropine; Brain; Chemical Warfare Agents; Cholinergic Fibers; Cholinesterase Inhibitors; Cholinesterase Reactivators; Drug Interactions; Female; Galantamine; Guinea Pigs; Lethal Dose 50; Male; Muscarinic Antagonists; Nerve Degeneration; Organ Culture Techniques; Organophosphate Poisoning; Organophosphorus Compounds; Sarin; Soman; Treatment Outcome

2010
Effectiveness of donepezil, rivastigmine, and (+/-)huperzine A in counteracting the acute toxicity of organophosphorus nerve agents: comparison with galantamine.
    The Journal of pharmacology and experimental therapeutics, 2009, Volume: 331, Issue:3

    Topics: Acetylcholinesterase; Alkaloids; Animals; Antidotes; Chemical Warfare Agents; Donepezil; Dose-Response Relationship, Drug; Galantamine; Guinea Pigs; Indans; Lethal Dose 50; Male; Phenylcarbamates; Piperidines; Poisoning; Rivastigmine; Sesquiterpenes; Soman; Time Factors; Toxicity Tests, Acute

2009
Magnetic resonance imaging reveals that galantamine prevents structural brain damage induced by an acute exposure of guinea pigs to soman.
    Neurotoxicology, 2010, Volume: 31, Issue:1

    Topics: Animals; Brain; Brain Mapping; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Female; Galantamine; Gene Expression Regulation; Guinea Pigs; Magnetic Resonance Imaging; Neurogranin; Neurotoxicity Syndromes; Nootropic Agents; RNA, Messenger; Soman; Time Factors

2010
Pretreatment of Guinea pigs with galantamine prevents immediate and delayed effects of soman on inhibitory synaptic transmission in the hippocampus.
    The Journal of pharmacology and experimental therapeutics, 2010, Sep-01, Volume: 334, Issue:3

    Topics: Animals; Antidotes; Cholinesterase Inhibitors; Data Interpretation, Statistical; Electrophysiology; Excitatory Postsynaptic Potentials; Female; Galantamine; gamma-Aminobutyric Acid; Guinea Pigs; Hippocampus; In Vitro Techniques; Lethal Dose 50; Patch-Clamp Techniques; Pyramidal Cells; Soman; Synaptic Transmission

2010
Galantamine counteracts development of learning impairment in guinea pigs exposed to the organophosphorus poison soman: clinical significance.
    Neurotoxicology, 2011, Volume: 32, Issue:6

    Topics: Animals; Behavior, Animal; Brain; Cholinesterase Inhibitors; Cognition; Cognition Disorders; Disease Models, Animal; Extinction, Psychological; Female; Galantamine; Guinea Pigs; Lethal Dose 50; Maze Learning; Motor Activity; Neuroprotective Agents; Nootropic Agents; Reaction Time; Soman; Time Factors

2011
Galantamine prevents long-lasting suppression of excitatory synaptic transmission in CA1 pyramidal neurons of soman-challenged guinea pigs.
    Neurotoxicology, 2014, Volume: 44

    Topics: Animals; Behavior, Animal; CA1 Region, Hippocampal; Cholinesterase Inhibitors; Excitatory Postsynaptic Potentials; Female; Galantamine; Guinea Pigs; Pyramidal Cells; Soman

2014
Neuroprotective Effects of Galantamine on Nerve Agent-Induced Neuroglial and Biochemical Changes.
    Neurotoxicity research, 2018, Volume: 33, Issue:4

    Topics: Acetylcholinesterase; Animals; Atropine; Brain; Brain-Derived Neurotrophic Factor; Galantamine; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Male; Muscarinic Antagonists; Nerve Agents; Neuroglia; Neuroprotective Agents; Protein Carbonylation; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; RNA, Messenger; S100 Calcium Binding Protein beta Subunit; Soman; Time Factors

2018
chemdatabank.com